cisplatin-epinephrine therapeutic implant

Known as: CEG, CDDP/epi gel, Cisplatin-E Therapeutic Implant 
An injectable gel comprised of a collagen matrix containing the inorganic platinum (Pt) agent cisplatin and the sympathomimetic agent epinephrine… (More)
National Institutes of Health

Related topics

Related topics

3 relations

Broader (1)

Cisplatin

Narrower (2)

IntradoseMP 5010 Therapeutic Implant

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
Rattle-structured multifunctional nanotheranostics for synergetic chemo-/radiotherapy and simultaneous magnetic/luminescent dual-mode imaging.
Most hypoxic tumors are insensitive to radiation, which is a major obstacle in the development of conventional radiotherapy for… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Highly Cited
2011
Highly Cited
2011
A randomized phase III trial (RTOG 0522) of concurrent accelerated radiation plus cisplatin with or without cetuximab for stage III-IV head and neck squamous cell carcinomas (HNC).
5500 Background: The concurrent use of cisplatin (CDDP) or cetuximab (CET) with radiation (RT) has been shown to improve survival… (More)
Is this relevant?
2011
2011
Risk-based classification system of nanomaterials
Various stakeholders are increasingly interested in the potential toxicity and other risks associated with nanomaterials… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
Is this relevant?
2006
2006
Poly(gamma,L-glutamic acid)-cisplatin conjugate effectively inhibits human breast tumor xenografted in nude mice.
An easily administered cis-dichlorodiammineplatinum (II) (CDDP) formulation with less toxicity and greater antitumor effect would… (More)
Is this relevant?
Highly Cited
2005
Highly Cited
2005
Protection against cisplatin-induced toxicities by N-acetylcysteine and sodium thiosulfate as assessed at the molecular, cellular, and in vivo levels.
Cisplatin (CDDP) is a common, highly toxic chemotherapeutic agent. This study investigates chemoprotective effects of N… (More)
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • figure 4
Is this relevant?
2005
2005
Randomized phase 3 trial of irinotecan (CPT-11) + 5FU/folinic acid (FA) vs CDDP + 5FU in 1st-line advanced gastric cancer patients
 
Is this relevant?
2003
2003
Usefulness of Tumor Volumetry as a Prognostic Factor of Survival in Head and Neck Cancer
The TNM classification system of tumor stage does not always reflect the actual tumor mass present at diagnosis. This study aimed… (More)
  • table 1
  • figure 1
  • figure 2
  • table 2
  • table 3
Is this relevant?
2001
2001
Role of the increase in p21 in cisplatin-induced acute renal failure in rats.
The goal of this study was to clarify the role of p21, a cyclin-dependent kinase inhibitor, in acute renal failure (ARF). This… (More)
Is this relevant?
1995
1995
Prophylaxis with intraoperative chemohyperthermia against peritoneal recurrence of serosal invasion-positive gastric cancer
Continuous hyperthermic peritoneal perfusion (CHPP) with a solution which contains 30 mg mitomycin C and 300 mg cisplatin has… (More)
  • table 1
  • figure 1
  • table 2
  • figure 2
  • figure 4
Is this relevant?
1993
1993
Prognosis of intracranial germ cell tumours: Effectiveness of chemotherapy with cisplatin and etoposide (CDDP and VP-16)
A co-operative study for patients with intracranial germ cell tumours was performed to analyze their prognosis and the… (More)
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Is this relevant?